- Report
- October 2024
- 184 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- October 2024
- 257 Pages
Global
From €4059EUR$4,250USD£3,394GBP
- Report
- October 2024
- 182 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- February 2025
- 180 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- July 2020
- 68 Pages
Global
From €2388EUR$2,500USD£1,997GBP
The Wearable Artificial Kidney (WAK) is a medical device designed to provide dialysis to patients with end-stage renal disease. It is a portable, battery-powered device that can be worn on the body, allowing patients to move freely while receiving dialysis. The device is designed to mimic the natural functions of the kidneys, filtering waste and excess fluid from the body. It is connected to the patient via a catheter, and the dialysis fluid is circulated through the device.
The WAK market is a rapidly growing segment of the medical device industry, with a focus on providing improved quality of life for patients with end-stage renal disease. The device is designed to provide a more comfortable and convenient dialysis experience, allowing patients to move freely and engage in activities that would otherwise be difficult or impossible.
Companies in the Wearable Artificial Kidney market include NxStage Medical, Baxter International, Fresenius Medical Care, and Asahi Kasei. Show Less Read more